Flow cytometric analysis of Human CD288 expression in Human PBMC. Human PBMC were fixed with 4% PFA and permeabilized with 0.1% Tween. The cells were stained with Brilliant Violet 421™ Mouse Anti-Human CD14 Antibody and either Allophycocyanin Mouse IgG2a, κ Isotype Control (Left panel) or SDT APC Mouse Anti-Human CD288 Antibody (Right panel) at 1.25 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD288 |
Synonyms | Toll-like receptor 8; TLR8 |
Accession | Q9NR97 |
Clone Number | S-2966 |
Antibody Type | Mouse mAb |
Isotype | IgG2a,k |
Application | ICFCM |
Reactivity | Hu |
Positive Sample | Human PBMC |
Purification | Protein A |
Concentration | 0.2 mg/ml |
Conjugation | APC |
Physical Appearance | Liquid |
Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
ICFCM | 1.25μl per million cells in 100μl volume | Hu |
Background
CD288 (also designated as Toll-like receptor 8, TLR8) is an 83 kDa type 1 transmembrane protein belonging to the TLR family, predominantly expressed in lung and peripheral blood leukocytes, and encoded by the TLR8 gene located on the X chromosome. It functions as an endosomal receptor that recognizes GU-rich single-stranded RNA (ssRNA) and G-rich oligonucleotides from viral pathogens (e.g., influenza, HIV, HCV), leading to recruitment of MyD88 and activation of NF-κB, thereby inducing proinflammatory cytokine synthesis and antiviral responses. Additionally, TLR8 (CD288) is involved in dendritic cell activation and the regulation of tumor growth, making it a target in cancer therapy research (e.g., ovarian cancer, lymphomas).
Picture
Picture
FC
